Aditxt acquires Ignite Proteomics for $36 million in cancer testing deal

March 13, 2026 8:15 AM

Aditxt Inc. (NASDAQ: ADTX) acquired Ignite Proteomics LLC for $36 million in preferred stock to expand its cancer diagnostic capabilities ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found